IL1B and pulmonary fibrosis: Similarly, BLM-sensitive IL-1 and TNF-α are produced in increasing amounts, and IL-1 receptor antagonists, anti-TNF antibodies and soluble TNF receptors alleviate the bleomycin-induced pulmonary fibrosis [42].